EICHORPublic-registry trials using Sucraid (sacrosidase) Oral Solution 8500 IU/mL that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| 7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels | QOL Medical, LLC | Congenital Sucrase-Isomaltase Deficiency | PHASE4 | 20 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
